Skip to main content
. 2021 Sep 16;11:18435. doi: 10.1038/s41598-021-97777-4

Figure 2.

Figure 2

Early endocytic crosstalk of GlialCAM and MLC1 trafficking dynamics. (A) The relative PM density of endogenous GlialCAM (GCAM) was measured using cs-ELISA in indicated cell lines and expressed as a percentage normalized for cellular proteins. (B) GCAM effect to increase the cellular expression of MLC1 variants (wt, P92S, C326R) was determined by immunoblotting (n = 8). (C) The PM stability of MLC1 variants was measured using cs-ELISA in the presence or absence of exogenous GCAM. (D) Exogenous GCAM enhances MLC1 variants [wt, P92S (PS), C326R (CR)] endosomal recycling, which was measured using cs-ELISA as described in “Materials and methods”. (E,F) The PM expression (E) and stability (F) of GCAM-wt and disease-causing GCAM-R92W were determined using cs-ELISA. GCAM-R92W (~ T1/2 < 1 h) was destabilized when compared to its wt counterpart (~ T1/2 2 h). (G) The impact of MLC1 variants [wt, P92S (PS), C326R (CR)] expression on the GCAM internalization was measured using cs-ELISA. (H) Comparison of the PM stability between overexpressed (tr) GCAM and endogenous GCAM (en) and upon coexpression of MLC1-C326R was measured using cs-ELISA. Means ± SEM, n ≥ 3, *p < 0.05, **p < 0.01, ***p < 0.001.